<?xml version="1.0" encoding="UTF-8"?>
<p>A number of animal models have been assessed for vaccine development and have been reviewed elsewhere [
 <xref rid="B51-tropicalmed-04-00104" ref-type="bibr">51</xref>]. Immunocompetent mice can develop transient viremia following infection and may represent models to test sterilizing immunity. Interferon α/β receptor knockout mice (AG129 or IFNAR -/-) develop lethal infection following Zika virus infection and have been used as a more stringent measure of protection. Non-human primates develop a self-limited mild illness associated with viremia and can transmit virus in utero to primate fetus [
 <xref rid="B52-tropicalmed-04-00104" ref-type="bibr">52</xref>].
</p>
